Author | Alessandro D. Santin, MD | OncLive

Author | Alessandro D. Santin, MD

Articles

Dr. Santin on Impact of Trastuzumab in Uterine Serous Carcinoma

April 24, 2018

Video

Alessandro D. Santin, MD, professor of obstetrics, gynecology, and reproductive sciences at Yale School of Medicine, discusses the impact of trastuzumab (Herceptin) in patients with uterine serous carcinoma.

Dr. Santin on Rationale for Trastuzumab in Uterine Serous Carcinoma

March 30, 2018

Video

Alessandro D. Santin, MD, professor of obstetrics, gynecology, and reproductive sciences at Yale School of Medicine, discusses the rationale for trastuzumab (Herceptin) in the treatment of patients with uterine serous carcinoma.

x